Substances · Cannabinoids (Indazole carboxamides)
ADB-PINACA
- Preferred name
- ADB-PINACA
- IUPAC name
- N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentylindazole-3-carboxamide
- Parent CAS number (reference)
- 1633766-73-0
- Molecular formula
- C19H28N4O2
- Molecular weight
- 344.5 g/mol
- InChIKey
- FWTARAXQGJRQKN-UHFFFAOYSA-N
- PubChem
- CID 86280478
- Source
- PubChem
- Verified synonyms & catalog abbreviations
-
ADBPINACA ADB PINACA
Verified Neurochemical & Toxicological Intelligence
ADB-PINACA
Receptor Telemetry & Mechanism of Action
Sub-nanomolar **full agonist** at both human CB1 (**EC50 = 0.52 nM**) and CB2 receptors (**EC50 = 0.88 nM**) in FLIPR membrane potential assays (Banister et al., 2015, PMID 26134475). Extending the 1-alkyl tail from 4 carbons (ADB-BUTINACA, EC50 = 6.36–11.5 nM) to 5 carbons (ADB-PINACA, EC50 = 0.52 nM) increases CB1 potency >12-fold, matching 5F-MDMB-PINACA (0.59 nM). Linked in CDC emergency-medicine investigations (Schwartz et al., 2015, PMID 25726258) to outbreaks of severe delirium, aggression, anxiety, hospitalizations, and deaths.
Biotransformation & Active Metabolites
Human hepatocyte HRMS studies (Carlier et al., 2017) identified 19 major metabolites led by pentyl hydroxylation, ketone formation, ADB-PINACA pentanoic acid, and glucuronidation.
Temporal Pharmacokinetics
Ultra-potent, fast-onset full-CB1 intoxication that escalates across an unforgiving microgram margin from intense physical stone into severe confusion, anxiety, agitated delirium, or unconsciousness.
- Onset 1–3 minutes inhaled
- Peak Window 10–30 minutes inhaled
- Total Window 1–2.5 hours inhaled (class estimate; clinical delirium hospitalizations lasted hours longer)
- Residual / Half-Life 2–8 hours of residual confusion, lethargy, and cardiovascular strain; formal human plasma half-life is unverified.
EXTREME SUB-NANOMOLAR HAZARD (CB1 EC50 = 0.52 nM): Functional potency rivals 5F-MDMB-PINACA (50 ug active threshold); exceeding ~250–300 ug (0.25–0.30 mg) risks CDC-documented severe delirium, aggression, convulsions, and coma. Volumetric dilution is mandatory—never eyeball powder.
Quantitative Response Spectrum (Published Literature)
Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.
15–35 ug (0.015–0.035 mg — tentative microgram estimate)
Subtle shift in perception, mild relaxation, and slowed time sense.
Slight heart-rate increase and faint dry mouth.
35–75 ug (0.035–0.075 mg — tentative microgram estimate)
Clear cannabimimetic mood elevation, sensory vividness, and calm detachment.
Dry mouth, conjunctival redness, and warm limb heaviness.
75–150 ug (0.075–0.15 mg — tentative microgram estimate)
Deep, heavy stone, pronounced time dilation, short-term memory suppression, and strong sedation.
Marked tachycardia, ataxia, dizziness, and drowsiness.
150–300 ug (0.15–0.30 mg — tentative microgram estimate)
Intense dissociation, disorientation, acute anxiety, hallucinations, and amnesia.
Severe motor loss, vomiting, palpitations, tremors, and risk of abrupt stupor.
300+ ug (0.30+ mg — tentative microgram estimate)
Severe CDC-documented agitated delirium, aggression, acute psychosis, or deep coma.
Seizures, severe cardiovascular instability, aspiration of vomit, respiratory depression, and death.
Interaction Matrix & Critical Contraindications
Critical Hazard — Never Combine
Profound synergistic coma, airway loss during emesis, and fatal respiratory arrest.
Sub-nanomolar full CB1 stacking triggers immediate convulsions, delirium, and fatal cardiorespiratory toxicity.
Extreme tachycardia, myocardial strain, severe delirium, and seizures.
Elevated Hazard — Avoid
Provokes agitated delirium, psychotic panic, and lowered seizure threshold.
Caution / Receptor Attenuation
Never combine with or apply to cannabis flower; overrides THC's safety ceiling.
Structural Isomer & Sibling Comparison
ADB-PINACA (CB1 EC50 = 0.52 nM) is the 5-carbon pentyl homologue of ADB-BUTINACA (4-carbon butyl, EC50 = 6.36–11.5 nM) and alkyl counterpart of ADB-FUBINACA (4-fluorobenzyl, EC50 = 0.98–1.2 nM). That extra carbon makes ADB-PINACA >12-fold more potent at CB1 than ADB-BUTINACA, placing it alongside 5F-MDMB-PINACA (0.59 nM) as the most extreme microgram-active cannabinoid in our catalog.
Physicochemical Stability & Storage
Physical Form: White to off-white neat crystalline solid or powder (NEVER supplied on sprayed herbs). · Soluble in ethanol, methanol, DMF, and DMSO; practically insoluble in water.
Store tightly sealed in a cool, dry, light-resistant container.
Cross-Tolerance & Dependence Profile
Rapid CB1 downregulation, cross-tolerance with all cannabinoids, and severe physical/psychological withdrawal upon abrupt cessation of frequent use.
Codes on this card
Short meanings for the abbreviations printed with this substance.
CB₁ / CB₂
Cannabinoid receptors CB1 and CB2
CB1 and CB2 are the two cannabinoid receptors named on these cards. Papers usually discuss CB1 in the nervous system and CB2 more often in immune tissue. The number beside them is often a Ki in nanomoles.
EC₅₀ / IC₅₀
Halfway concentration
EC50 is the concentration where a lab saw half of the maximum measured effect. IC50 is the concentration where it saw half of the maximum block. Smaller means that halfway point came at a lower concentration.
Kᵢ
Binding tightness in nanomoles
Ki says how tightly a compound sits on a receptor in a binding test. It is written in nanomoles per litre. A Ki of 1 nM means very tight binding in that experiment.
ratio
Selectivity ratio
A selectivity ratio divides two halfway numbers, such as SERT EC50 by DAT EC50, to show which target the assay reached first. The direction of the division has to be stated, or the number flips.
CAS
CAS registry number
A CAS number is a passport number for one chemical entry in the CAS registry. The free base and a salt of the same parent usually have different CAS numbers.
IUPAC
IUPAC Name & Molecular Formula
The molecular formula counts how many atoms of each element sit in one molecule, while the IUPAC name is the systematic map showing exactly how those atoms are connected.
CID / InChIKey
PubChem CID & Standard InChIKey
PubChem CID is the catalog number in the U.S. National Library of Medicine chemistry database, and InChIKey is a 27-character digital fingerprint of the molecule's exact 3D structure.
1 mg / µg
Calibrated Physical Form (1 mg Tablets, µg Liquid, Crystal)
Milligram-scale benzodiazepines are supplied as 1 mg tablets (1 tablet = 1 mg), microgram lysergamides as dissolved liquid (µg), and standard compounds as pure crystal or powder.
Chemical Architecture & Structural Profile
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentylindazole-3-carboxamide) is a reference compound belonging to the Cannabinoids (Indazole carboxamides) class, characterized by the molecular formula C19H28N4O2 and a molar mass of 344.5 g/mol. The parent molecule is indexed under CAS registry number 1633766-73-0 and in the NCBI PubChem database as CID 86280478 (Standard InChIKey: FWTARAXQGJRQKN-UHFFFAOYSA-N).
Citations
- PubChem — PubChem (2026-11-12)
Reference Toxicology & Safety Profile
In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), ADB-PINACA is indexed within the Cannabinoids (Indazole carboxamides) structural group. Synthetic indazole carboxamide exhibiting high receptor affinity in in-vitro assays; requires calibrated micro-analytical balances and full dermal and respiratory protection. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.
Citations
- PubChem — PubChem (2026-11-12)
Analytical Use & Laboratory Notice
This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.
Citations
- Riksdagen — Förordning (1999:58) om förbud mot vissa hälsofarliga varor — Sveriges riksdag (2026-11-12)